CYRAMZA (Ramucirumab) is used for the treatment of patients with stomach cancer, colorectal cancer, or non-small cell lung cancer

Ramucirumab is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body. Ramucirumab may be given alone or in combination with other cancer medicines.

CYRAMZA (Ramucirumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of CYRAMZA (Ramucirumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the CYRAMZA (Ramucirumab) medicine cost price in India.

The order for CYRAMZA (Ramucirumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

CYRAMZA (ramucirumab) injection, for intravenous use. Initial U.S. Approval: 2014

Generic Name: Ramucirumab

Injection: 100 mg/10 mL (10 mg/mL) or 500 mg/50 mL (10 mg/mL) solution in a single-dose vial.

Ramucirumabfor injection

Get In Touch

CYRAMZA (Ramucirumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand CYRAMZA (Ramucirumab) on prescription and Import License in Patient's Name only.

For overseas patients, CYRAMZA (Ramucirumab) can be made available in Send your enquiry to find CYRAMZA (Ramucirumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for CYRAMZA (Ramucirumab).

For CYRAMZA (Ramucirumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

CHMP Issues Positive Opinion to Expand CYRAMZA® (ramucirumab) Label to Include Results from RELAY Study in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer For More Details

Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma For More Details

Channel Partner In India

NEW DELHI OFFICE

  • Address:60/4, T&T House. Yusuf Sarai, New Delhi:110016
  • Phone +91-11-26532129
  • Email: IPN, New Delhi

BANGALORE OFFICE

  • Address: #308, Raheja Chambers, 12, Museum Road, Bangalore 560 001
  • Email: IPN, Bangalore

KOLKATA OFFICE

  • Address: 1/A R.G Kar Road, Shayambazar, Kolkata 700004
  • Email: IPN, Kolkata

LUCKNOW OFFICE

  • Address: 203-A, 2nd Floor, Tower -11, Felix Square, IBB-2, Sushant Golf city, Lucknow 226030
  • Email: IPN, Lucknow